Kraig Biocraft Laboratories (KBLB) Cash from Financing Activities (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Cash from Financing Activities across 16 years of filings, most recently posting $602198.0 for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $602198.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (up 7102.33% YoY), and the FY2025 annual result was $2.5 million, up 7102.33% from the prior year.
• Cash from Financing Activities came in at $602198.0 for Q4 2025 at Kraig Biocraft Laboratories, down from $1.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $3.3 million in Q2 2021 to a low of -$15000.0 in Q3 2022.
• The 5-year median for Cash from Financing Activities is -$5244.0 (2024), against an average of $508360.6.
• Across the five-year window, Cash from Financing Activities sank 120.33% in 2022 and jumped 19538.12% in 2025, its largest moves.
• Kraig Biocraft Laboratories' Cash from Financing Activities stood at $73774.0 in 2021, then tumbled by 120.33% to -$15000.0 in 2022, then changed by 0.0% to -$15000.0 in 2023, then surged by 65.04% to -$5244.0 in 2024, then soared by 11583.56% to $602198.0 in 2025.
• The last three Cash from Financing Activities figures came in at $602198.0 (Q4 2025), $1.0 million (Q3 2025), and $688131.0 (Q2 2025), per Business Quant data.